概述CD70作为骨髓肉瘤潜在治疗点的概述
Emily Rav1, Shinji Maegawa1, Vidya Gopalakrishnan1
1Division of Pediatrics, Department of Pediatrics Research, The University of Texas MD Anderson Cancer Center, Houston, TX.
Journal of immunology (Baltimore, Md. : 1950)
|September 18, 2023
概括
向分化集群70 (CD70) 在骨髓瘤治疗方面表现有前途. 虽然存在挑战,但正在进行的基于CD70的疗法为患有这种骨癌的患者提供了新的希望.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 分子生物学分子生物学
背景情况:
- 骨髓瘤是一种主要的骨癌,对耐火病例的有效治疗方法有限.
- 目前的化疗对晚期骨髓瘤没有生存益处.
- 基于免疫的细胞疗法正在成为替代品,特别是当设计以准特定瘤抗原时.
研究的目的:
- 审查分化集群70 (CD70) 作为骨髓瘤治疗点的作用.
- 突出在骨髓瘤治疗中针对CD70的好处和挑战.
主要方法:
- 关于骨髓瘤中CD70表达和功能的最近研究的文献综述.
- 分析CD70与免疫逃避和瘤扩散的相关性.
- 对正在进行的基于CD70的骨髓瘤临床试验的审查.
主要成果:
- 分化集群70 (CD70) 在骨髓癌肺转移中高度表达.
- 过度表达CD70与免疫逃避和瘤扩散有关.
- 基于CD70的骨髓瘤临床试验的初步结果是有希望的.
结论:
- CD70代表了骨髓瘤免疫治疗的有希望的目标.
- 需要进一步的研究来解决诸如非目标效应等挑战,并了解CD70在正常组织中的表达.
- 针对CD70的疗法有可能改善骨髓瘤患者的治疗结果.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Rous Sarcoma Virus (RSV) and Cancer
5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.1K
Tumor Immunotherapy
554
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
554
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


